Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled TrialAnders Jorsal, Lise Tarnow, Henrik Wiggers et al.|European Journal of Heart Failure|2016Cited by 561
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysisPeter Willeit, Mary Cushman, Torben Jørgensen et al.|The Lancet Diabetes & Endocrinology|2016Cited by 221